Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caribou Biosciences (CRBU) Amortizatization of Intangibles (2021 - 2025)

Caribou Biosciences (CRBU) has disclosed Amortizatization of Intangibles for 5 consecutive years, with $160000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Amortizatization of Intangibles fell 84.28% to $160000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $1.1 million, a 75.88% decrease, with the full-year FY2025 number at $1.1 million, down 75.88% from a year prior.
  • Amortizatization of Intangibles was $160000.0 for Q4 2025 at Caribou Biosciences, down from $235000.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $2.4 million in Q3 2023 to a low of -$1.6 million in Q4 2023.
  • A 5-year average of $649176.5 and a median of $452000.0 in 2025 define the central range for Amortizatization of Intangibles.
  • Peak YoY movement for Amortizatization of Intangibles: surged 1836.54% in 2022, then plummeted 279.07% in 2023.
  • Caribou Biosciences' Amortizatization of Intangibles stood at -$52000.0 in 2021, then soared by 1836.54% to $903000.0 in 2022, then tumbled by 279.07% to -$1.6 million in 2023, then skyrocketed by 162.96% to $1.0 million in 2024, then crashed by 84.28% to $160000.0 in 2025.
  • Per Business Quant, the three most recent readings for CRBU's Amortizatization of Intangibles are $160000.0 (Q4 2025), $235000.0 (Q3 2025), and $293000.0 (Q2 2025).